Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2000

01-12-2000 | Paper Report

Pathologic features associated with nonsentinel lymph node metastasis

Author: Rodolfo Laucirica

Published in: Breast Cancer Research | Issue 1/2000

Login to get access

Excerpt

In the appropriate clinical and mammographic setting, SN mapping and biopsy are currently used for the regional control of metastatic breast cancer. Although there are insufficient data to draw definitive conclusions regarding this form of limited nodal surgery, accurate pathologic assessment of the primary tumor and SNs should provide useful information for adjuvant therapeutic decisions. …
Literature
1.
Turner RR, Chu KU, Qi K, Botnick LE, Hasen NM, Glass EC, Giuliano AE: Pathological features associated with nonsentinel lymph node metastasis in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer. 2000, 89: 574-581.CrossRefPubMed
Metadata
Title
Pathologic features associated with nonsentinel lymph node metastasis
Author
Rodolfo Laucirica
Publication date
01-12-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr-2000-66714

Other articles of this Issue 1/2000

Breast Cancer Research 1/2000 Go to the issue

Commentary

The mammary myoepithelial cell - Cinderella or ugly sister?

Paper Report

Multigene expression patterns predict metastatic behavior

Paper Report

Tailored versus high-dose chemotherapy as adjuvant breast cancer treatment

Paper Report

Chromosome 6 alterations

Paper Report

What do Dictyosteliumand mammary gland have in common?

Paper Report

Dual HER-2/EGFR tyrosine kinase inhibitors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits